I-Chen Tsai
Papers
1
Total Citations
2
H-Index
1
About
Dr. I-Chen Tsai is a pioneering urologic surgeon whose work centers on advancing minimally invasive techniques for renal cancer treatment. His primary research focuses on refining robot-assisted partial nephrectomy (RAPN), particularly through innovative retroperitoneal approaches and fluorescence-guided imaging. Dr. Tsai’s major contribution is the development of superselective transarterial indocyanine green (ICG)-lipiodol embolization, a technique that precisely delineates tumor margins in totally endophytic renal masses during RAPN. This method enhances surgical precision by enabling real-time, fluorescence-guided tumor localization, potentially reducing positive margins and preserving healthy kidney tissue. His landmark 2024 study, which demonstrated the feasibility of this approach in eight patients, has garnered early attention with 2 citations, signaling its growing impact in the field. By pioneering the retroperitoneal route for ICG-guided embolization, Dr. Tsai addresses a critical challenge in nephron-sparing surgery for complex, deeply embedded tumors. His work promises to expand the boundaries of what is achievable with robotic surgery, offering patients improved oncologic and functional outcomes. Dr. Tsai’s innovative integration of interventional radiology and robotic techniques marks him as a rising leader in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1